Physician profile
Guy D Picard
NPI 1134104490
$806.62
in general payments reported to CMS, 2019-2025
9 companies · $177 in 2025
The $177 reported for 2025 was more than what 87% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $131 · 2023: $209 · 2024: $115 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.91 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $252.68 | 2021-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $43.69 | 2023 | Remicade, Simponi, Stelara |
| Lilly USA, LLC | $31.40 | 2024-2025 | Omvoh |
| Ardelyx, INC. | $18.09 | 2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $16.09 | 2022 | |
| Braintree Laboratories, INC. | $14.56 | 2025 | Sutab, Suflave |
| Mallinckrodt Hospital Products INC. | $14.42 | 2023 | Terlivaz |
| Merck Sharp & Dohme LLC | $13.78 | 2024 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Picard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.